“…The application of cryosurgery to a variety of normal and pathologic tissues has demonstrated that in situ freezing of many tissues constitutes an antigenic stimulus (comparable to that obtained through the parenteral administration of antigen), capable of generating a specific immunologic response to autologous antigens of the frozen tissue, ergo, cryostimulation [19]. Interest in the phenomenon of cryostimulation, spurred in part by reports of secondary tumor cell destruction beyond the freezing site, i.e., of distant metastases [8,12,20,21], has prompted continuing investigation into the applicability of cryosurgery, not only for destruction of primary tumor, but also for augmentation of induction of host resistance to tumor, ergo, cryoimmunotherapy [2], However, if cryosurgery is to be efficaciously employed not only for ablation of tumor [4,17], but also as a possible means of engendering an immunologic response to tumor (primary as well as secondary, i.e., metastases) [8], several factors must be given careful consideration [1], Evolving from initial experimental studies [10], these factors have been referred to as the 'cryosensitivity' of the host [5], and may tentatively and generally said to be related, as outlined in table I, to: (i) the immunogenicity of the target tissue, i.e., the tissue frozen, and (ii) the immunocompetency of the host.…”